Camp4 Therapeutics is at the forefront of developing a new class of medicines by targeting regulatory RNAs (regRNAs) to precisely control gene expression. Their proprietary platform aims to unlock the potential of the cellular signaling-regulatory network, enabling the discovery and development of programmable therapeutics for a broad spectrum of genetic and common diseases. By understanding and modulating the 'instruction manual' of gene expression, Camp4 seeks to address conditions previously considered undruggable.
Primary research and development laboratories, corporate leadership, and operational hub for pioneering RNA-targeting therapeutics and advancing the company's drug discovery platform.
Located within the vibrant One Kendall Square campus, offering access to state-of-the-art facilities, a dense network of academic and industry collaborators, and a dynamic environment conducive to cutting-edge scientific research.
Camp4 fosters a science-driven, innovative, and collaborative work culture. Employees are encouraged to be bold and creative, working together in a fast-paced environment dedicated to translating groundbreaking science into impactful medicines for patients.
The Cambridge headquarters is strategically vital, placing Camp4 at the epicenter of biotechnological advancement, facilitating talent acquisition, scientific partnerships, and access to world-class research infrastructure.
While Camp4 Therapeutics' primary operations and headquarters are centralized in Cambridge, MA, the company is focused on developing novel medicines with the potential for global impact. Their research, clinical development strategies, and future commercialization efforts are designed to address diseases affecting patient populations worldwide, involving international collaborations and regulatory interactions as their pipeline advances.
One Kendall Square, Building 1400W, Suite 14-201
Cambridge
MA
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, CAMP4 Therapeutics' leadership includes:
CAMP4 Therapeutics has been backed by several prominent investors over the years, including:
In the past 12 months, Camp4 Therapeutics has significantly strengthened its executive leadership team with key appointments in finance, medical, and people operations, reflecting its growth and strategic focus. No major executive departures were publicly announced during this period.
Discover the tools CAMP4 Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Camp4 Therapeutics commonly uses the first initial followed by the last name for their email addresses. This is a frequent pattern in many biotechnology and corporate environments.
[first_initial][last]@camp4tx.com
Format
jdoe@camp4tx.com
Example
90%
Success rate
Business Wire • April 3, 2024
Camp4 Therapeutics announced it will present new preclinical data for CMP4-001, its lead RNA activator targeting Dravet syndrome and other SCN1A-related epilepsies, at the AAN 2024 Annual Meeting....more
Business Wire • December 12, 2023
Camp4 Therapeutics announced the appointment of Adam M. Pires as its Chief Business and Financial Officer, effective January 2024....more
Business Wire • June 28, 2023
Camp4 Therapeutics announced the appointment of Ann C. Barbier, M.D., Ph.D., as its Chief Medical Officer....more
Business Wire • May 10, 2023
Camp4 Therapeutics announced the appointment of Kelly G. Copes-Anderson as its Chief People Officer....more
Business Wire • February 7, 2023
Camp4 Therapeutics announced the closing of an oversubscribed $100 million Series B extension financing round, co-led by existing investor Northpond Ventures and a new, undisclosed global life sciences investor....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including CAMP4 Therapeutics, are just a search away.